![Peter Keller](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter Keller
Chief Executive Officer at Bluewhale Bio, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Moncef Slaoui | M | 64 |
Monopteros Therapeutics, Inc.
![]() Monopteros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Monopteros Therapeutics, Inc. manufactures pharmaceuticals. | - |
Ulrich von Andrian | M | - |
Monopteros Therapeutics, Inc.
![]() Monopteros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Monopteros Therapeutics, Inc. manufactures pharmaceuticals. | - |
Debasish Francois Roychowdhury | M | 63 |
Monopteros Therapeutics, Inc.
![]() Monopteros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Monopteros Therapeutics, Inc. manufactures pharmaceuticals. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
David Abraham | M | 58 | 7 years | |
David Siewers | M | 71 | 8 years | |
Ann Donohue | F | 43 | - | |
Timothy Springer | M | 76 | - | |
Patrick Zenner | M | 77 | - | |
Ed Kania | M | 66 | - | |
Timothy Barabe | M | 71 | - | |
Carl Gordon | M | 59 | 7 years | |
John Leaman | M | 51 | 2 years | |
Peter Edwards | M | 62 |
Solvay Pharmaceuticals SA
![]() Solvay Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Solvay Pharmaceuticals SA develops, manufactures, and supplies pharmaceutical products. The company's products include cardio-metabolics, influenza vaccines, adjuvants, and women's and men's healthcare products. It offers fenofibrate, a cardio-metabolic product for treating raised blood lipids and dyslipidemia products that control cholesterol and triglycerides. The firm is headquartered in Brussels, France. | 3 years |
Earl Sands | M | 66 | 4 years | |
Filip Goossens | M | - |
Solvay Pharmaceuticals SA
![]() Solvay Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Solvay Pharmaceuticals SA develops, manufactures, and supplies pharmaceutical products. The company's products include cardio-metabolics, influenza vaccines, adjuvants, and women's and men's healthcare products. It offers fenofibrate, a cardio-metabolic product for treating raised blood lipids and dyslipidemia products that control cholesterol and triglycerides. The firm is headquartered in Brussels, France. | 1 years |
Stephen Smolinski | M | 59 | 3 years | |
Takashi Kishimoto | M | 64 | 12 years | |
Leysan Shaydullina | M | 45 | - | |
Ronan O’Brien | M | 52 | 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 17 | 89.47% |
Belgium | 2 | 10.53% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Peter Keller
- Personal Network